Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 18, Issue 3, Pages 266-273
Publisher
Wiley
Online
2015-11-23
DOI
10.1111/dom.12608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter
- (2015) R. E. J. Ryder DIABETIC MEDICINE
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chemotherapy and Chemoprevention by Thiazolidinediones
- (2015) Eleonore Fröhlich et al. Biomed Research International
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
- (2014) Sang-Man Jin et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
- (2014) Sophia Zoungas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational follow-up of the PROactive study: a 6-year update
- (2013) E. Erdmann et al. DIABETES OBESITY & METABOLISM
- Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study
- (2013) Fei-Yuan Hsiao et al. DRUG SAFETY
- Pioglitazone use and the risk of bladder cancer
- (2013) Hsin-Wei Kuo et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Pioglitazone and bladder cancer: a propensity score matched cohort study
- (2012) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
- (2012) Kanta Fujimoto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
- (2012) L. Azoulay et al. BMJ-British Medical Journal
- The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
- (2012) Sun Ok Song et al. Diabetes & Metabolism Journal
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
- (2011) T. P. van Staa et al. DIABETOLOGIA
- Pioglitazone and bladder cancer – Authors' reply
- (2011) Erland Erdmann et al. LANCET
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11)
- (2008) J.A. Dormandy et al. ATHEROSCLEROSIS
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started